Endocyte Reaches Analyst Target Price
October 19, 2018 at 07:59 AM EDT
In recent trading, shares of Endocyte Inc (ECYT) have crossed above the average analyst 12-month target price of $23.33, changing hands for $23.39/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..